Trimetazidine tmz
Trimetazidine (TMZ) is a pharmaceutical compound primarily used in the treatment of angina pectoris. It acts as a metabolic modulator, shifting myocardial energy production from fatty acid oxidation to glucose oxidation, which can improve the efficiency of myocardial oxygen utilization. TMZ is approved for medical use in several countries, including the European Union, for the treatment of stable angina pectoris.
Lab products found in correlation
2 protocols using trimetazidine tmz
Reagents for Macrophage Metabolism Analysis
Trimetazidine, Heparin, and Alloxan Protocol
(St. Louis, MO, U.S.A.) and Ketamine and xylazine purchased from Alfasan Co
(Woderen- Holland).
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!